AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"!

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026

Currently Viewing Abstracts from 2026

Title
“I Didn’t Know It Was Addictive”: Severe Kratom and 7- Hydroxymitragynine Dependence in a Young Adult
A Harm Reduction Approach to Overdose Recognition and Naloxone Training in an FQHC Serving Unhoused Individuals
A Pharmacist-Led Initiative to Improve Stimulant Monitoring Compliance in Patients at A Veteran Affairs Healthcare System
A Pharmacist-Led Initiative to Improve Stimulant Monitoring Compliance in Patients at A Veteran Affairs Healthcare System
A Randomized Crossover Study Evaluating Dose Proportionality of a Novel Lithium Carbonate Extended-Release (XR) 600 mg and 900 mg Bi-Layer Matrix Formulation Under Fed Conditions in Healthy Adults
A Randomized, Three-Way Crossover Study Evaluating the Bioavailability of a Novel Single Dose Once-Daily Lithium Carbonate Extended-Release (XR) Bi-Layer Matrix Formulation Compared With Two-Times-Daily and Three-Times-Daily Lithium Regimens in Healthy Ad
A Randomized, Two-Way Crossover Study Evaluating the Steady-State Bioequivalence of a Novel Once-Daily Lithium Carbonate Extended-Release (XR) 900 mg Bi-Layer Matrix Formulation Compared With Two-Times-Daily Lithium Carbonate Extended-Release 450 mg Formu
A Retrospective Evaluation on the Appropriate Use, Safety, and Clinical Outcomes of Subcutaneous Risperidone Extended-release Injectable Suspension Compared to Intramuscular Paliperidone Palmitate
A Secondary Analysis of the Relationship Between Cocaine Craving and Depression
A Subanalysis From a Study Assessing the Interaction Between Lithium and GLP-1 Receptor Agonists: A Case Level Assessment of Lithium Toxicity
A University-Led Interprofessional Mobile Model for Whole-Person Community Care
Addressing Psychiatric Mental Health Disparities Using an Interprofessional Practice Approach
Adherence to Laboratory Monitoring Protocols for Mood Stabilizers in an Inpatient Psychiatric State Hospital
Adherence to Metabolic Syndrome Monitoring Guidelines in Veterans Receiving Long-Acting Injectable Antipsychotics: A Retrospective Chart Review
Adjunctive Lumateperone in Patients With Major Depressive Disorder and Anxious Distress
Administration Patterns of Paliperidone Long-Acting Injectables: A Retrospective Analysis in Minnesota Behavioral Health Pharmacies
An Evaluation of Clozapine – Associated Myocarditis Monitoring Order Set Implementation
An Evaluation of Over-the-Counter Supplement Use, Documentation, and Clinician Engagement in an Outpatient Behavioral Health Clinic
Antipsychotic Burden and Length of Stay in a State Psychiatric Hospital: A Retrospective Cohort Study
Antipsychotic Stewardship in an Outpatient Mental Health Clinic Within the Veterans Health Administration
Anxiolytic Effects of Dextromethorphan-Bupropion (45mg/105mg): Post Hoc Analyses Across Trials in Major Depressive Disorder
Appropriateness of Metabolic Monitoring for High-Risk Second-Generation Antipsychotics
Assessing Appropriate Transitions of Care for Patients with Alcohol Use Disorders
Assessing Clinical Pharmacists’ Perspective on Clozapine REMS Removal
Assessing the Effectiveness of an Interprofessional Education Program for Reducing Health Professions Student Stigma of Formerly Incarcerated Individuals
Assessing the Impact of Pharmacist-Led Education on Veterans’ Acceptance of Alcohol Use Disorder or Opioid Use Disorder Services
Assessing the Management of Medetomidine Intoxication and Withdrawal: A Literature Review
Assessment of Facility Compliance with Absolute Neutrophil Count (ANC) Monitoring Before and After Elimination of the FDA Clozapine REMS Program
Assessment of Off-Label Quetiapine Prescribing Practices and Safety Outcomes
Assessment of Recreational Cannabis Legalization on THC Positive Admissions for Psychosis at a VA Medical Center
Assessment of the Impact of an Inpatient Clinical Pharmacist Practitioner Consult Service for Medication for Alcohol Use Disorder
Assessment of Therapeutic Outcomes of Buprenorphine Micro-Induction
Association Between AAPP Student Chapter Membership and Pursuit of Psychiatric Pharmacy Residency Training
Association of Long-Acting Injectable (LAI) Medication Adherence and Distance to a Facility in an Urban Healthcare System
Barriers to Accessing Mental Health Resources Among Graduate Students in Medical Programs: A Cross-Sectional Survey
Beyond Stimulants: Antidepressants for Pediatric Attention-Deficit/Hyperactivity Disorder- Efficacy and Safety
Beyond the Books: Measuring Effects of a Wellness Program on Pharmacy Students' Well-being
Bridging Care with Pharmacy Students in Pharmacist-Led Long-Acting Injectable Antipsychotic Transitions
Bridging the Gap in Clozapine Re-titration Practices and Outcomes Following Brief Interruption
Buprenorphine for Kratom Use Disorder in a Veteran Population: A Case Series and Literature Review
Burnout and Well-Being Among Pharmacy Technicians across a Hospital System
Characterization of Adjunctive Antipsychotic Therapy in the Treatment of Depressive Disorders in Older Adults
Characterization of Discharge Insulin Regimens at an Inpatient Psychiatric Hospital
Clinical and Economic Impact of Hospital Inpatient Free Trial Program Participation at a Start Up Behavioral Health Hospital During Opening Year
Clinical Outcomes of GLP-1 Receptor Agonists FDA-Approved for Weight Management in Patients with Binge Eating Disorder: A Systematic Review
COMP 005 and COMP 006: Approaches to Challenges in Randomized-Controlled Clinical Trials with Psychedelics
Comparative Effects of Risperidone Extended-Release Subcutaneous Injection Versus Paliperidone Palmitate Intramuscular Injection on Patient Outcomes Post Discharge
Comparing the Impact of Tetrahydrocannabinol (THC) on 30-day Readmission Rates and Hospital Length of Stay in Patients with Depression
Comparison of Clinical Outcomes Between Subcutaneous and Intramuscular Long-Acting Injectable Antipsychotics in the Outpatient Setting
Comparison of Long-acting Injectable Risperidone Products
Comparison of Outcomes Among D2 Receptor Partial Agonists for Augmentation in Major Depressive Disorder
Comparison of Parenteral Lorazepam vs Midazolam in Combination with Antipsychotics for Acute Agitation in Pediatric Patients
Compulsive Sexual Behavior Management Without Anti-androgens: SSRI and PRN Use in a State Psychiatric Hospital
Continuity of Long Acting Injectable Antipsychotics
Creation of a Pharmacotherapy Laboratory Experience for Long-Acting Injectable Antipsychotic Medications Given by Gluteal Administration
Crystal Clear Guidance on Recognizing and Managing Methamphetamine-Induced Psychosis
Describing the Role of a Board-Certified Psychiatric Pharmacist in a Community-Based First Episode Psychosis Clinic
Development and Application of PBPK Models for Cariprazine and Its Active Metabolites to Predict CYP3A-Mediated Drug-Drug Interactions and Inform Dose Adjustment Strategies
Diagnosis and Treatment of Anxiety or Depression Following Clostridioides difficile Infection
Difference in Length of Hospitalization between Risperidone Extended-Release Injection vs. Paliperidone Palmitate
Don't Be Rash! Safety of Lamotrigine Rapid Titrations
Dosing to Effect With Weekly and Monthly Subcutaneous Buprenorphine: Post Hoc Analysis of a Phase 3, Open-label Study
Droperidol versus Haloperidol for Severe Agitation in the Emergency Department
Effect of Pharmacy Student Graduation and Residency Rates on Subsequent Board Certification Rates
Effects of a Curricular Long Acting Injectable (LAI) Antipsychotic Workshop on Student Pharmacists’ Readiness and Confidence to Administer LAIs
Effects of High Sensory-Processing Sensitivity On Stress Levels And Academic Performance of College Students
Efficacy and Sleep Outcomes of Viloxazine Extended-Release in a Decentralized Trial of Adults with ADHD and Mood Symptoms based on Self-Reported Cannabis Use
Elinzanetant as a Dual Neurokinin-1/3 Receptor Antagonist in Menopausal Vasomotor Symptom Management: A Scoping Review
Empagliflozin and False Positive for Ethanol on Urine Toxicology: a Case Report
EMPOWERing (Eliminating Medications through Patient OWnership of End Results) Change: A Strategic Approach to Deprescribing Benzodiazepines
Enhancing Measurement Based Care Through Mental Health Interdisciplinary Team Collaboration
Establishing a Free Valproic Acid (VPA) Therapeutic Range for Affective Disorders: A Retrospective Analysis
Establishment of a Pharmacist-Integrated Opioid Use Disorder Service
Evaluating Clozapine Monitoring After The Removal of Risk Evaluation and Mitigation Strategies (REMS)
Evaluating Secure Messaging as a Tool for Alcohol Use Disorder (AUD) Pharmacotherapy Outreach in Patients with Elevated Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) Scores
Evaluating the Evidence of Glucagon-Like Peptide-1 Receptor Agonists on Neurocognition
Evaluating the Impact of DEA-Licensed Clinical Pharmacist Practitioners on Prescribing Practice of Buprenorphine in Veterans
Evaluating the Relationship Between Anticholinergic Cognitive Burden and Antipsychotic Burden in Patients With Schizophrenia or Schizoaffective Disorder Admitted To an Inpatient Psychiatric Hospital
Evaluating the Safety of Coadministration of Intramuscular Olanzapine and Benzodiazepines for Agitation in the Emergency Department
Evaluating Time to Competency with Antipsychotic Strategies in Treatment-Resistant Schizophrenia at Forensic Psychiatric Facility
Evaluation of a clinical pharmacist practitioner’s impact on Veterans Health Administration metrics related to opioid safety through population health dashboard monitoring at a Veteran Affairs Health Care System
Evaluation of a Pharmacist-Led Wraparound Service Delivered Through a Medicaid Organization to Support Post-Discharge Continuity of Long-Acting Injectable Antipsychotics
Evaluation of a Psychiatric Pharmacist–Led Inpatient Lithium Test-Dose Protocol
Evaluation of a Scoring Tool to Identify High-Risk Discharges in Psychiatric Transitions of Care
Evaluation of Appropriate Z-Drug Prescribing and Deprescribing at a Large VA Medical Center
Evaluation of Implementation of Mental Health Clinical Pharmacist Practitioners in Post Discharge Follow-up after an Inpatient Mental Health Discharge
Evaluation of laboratory monitoring in patients on antipsychotics using the Psychotropic Drug Safety Initiative (PDSI) database
Evaluation of Pharmacist Intervention to Improve Tobacco Use Screening Reminder Completion During Admission to an Inpatient Psychiatric Ward
Evaluation of Pharmacist-Led Medication-Assisted Treatment (MAT) Groups in Outpatient Mental Health Clinics
Evaluation of Sexual Function With Adjunctive Lumateperone in Patients With Major Depressive Disorder
Evaluation of the Impact of Illness Management and Recovery (IMR) Group Attendance on Medication Adherence in a Forensic Psychiatric Facility
Evaluation of the Impact of Pharmacogenomics Clinical Decision Support on Psychiatric Medications
Evaluation of Viloxazine ER with and without Concomitant Stimulant Use in a Decentralized Trial of Adults with ADHD and Symptoms of Depression and Anxiety
Expanding Primary Care–Mental Health Integration Through Pharmacist-led Medication Management Across Community-Based Outpatient Clinics
Exploring the Relationship between Gen-Z Internet Access and Self Diagnosing of ADHD
From Post-Transplant Delirium to Neuroleptic Malignant Syndrome: A Case of High-Dose Antipsychotic Exposure
High Dose versus Standard Dose Naltrexone for Alcohol Use Disorder
Hypnotic Use in an Adolescent Inpatient Behavioral Facility
Impact of a Pharmacist-Led Abnormal Involuntary Movement Scale Service
Impact of a Student-Driven Journal Club Initiative for AAPP Collegiate Chapters
Impact of an Advanced Psychiatric Pharmacy Elective on Pharmacy Students’ Comfort, Attitudes, and Perceptions Toward Mental Health Conditions
Impact of Antidepressant Use on Bleeding Risk in Patients with Solid Tumor Malignancies
Impact of Clinical Pharmacists on Cost Avoidance in an Epilepsy Clinic
Impact of CYP2D6-Inhibiting Antidepressants on Beta-Blocker Dosing and Safety Outcomes in Heart Failure
Impact of Implementation of Formulary Preferred Risperidone Extended-Release Injectable Suspension on Prescribing Patterns
Impact of Lifetime Substance Use Disorder of Psychiatric Symptoms and Treatment Outcomes for Black Adults Treated with Clozapine
Impact of Long-Acting Injectable Antipsychotics on 30-day and 90-day Readmission Rates in Adolescent Patients
Impact of Medication Education and Clean Syringe Exchange from Harm Reduction Program Initiated at a VA Healthcare System
Impact of Mental Health First Aid Training on Knowledge and Attitudes in California Pharmacy Professionals
Impact of Oral Overlap During Initiation of Subcutaneous Risperidone Extended-Release Injectable on Clinical and Safety Outcomes
Impact of Pharmacist-Driven Chart Reviews on HbA1c and Glucose Monitoring in Veterans on Antipsychotics
Impact of Tirzepatide on Binge Eating Behaviors: A Case Report
Implementation and Evaluation of a Psychiatric Pharmacist-Led Medication for Opioid Use Disorder Clinic in an Underserved Outpatient Setting
Implementation of a Medication Assisted Therapy Pharmacy Service Line at a Rural, Critical Access Indian Health Service Unit
Implementation of a Pharmacist-Led Workflow for Managing Second-Generation Antipsychotic Weight Gain in an Inpatient Psychiatric Facility
Implementation of a Standardized Psychiatric Pharmacist Protocol in an Inpatient Substance Use Disorder Program
Implementation of an Adherence‑Based Contingency Management Program for Long‑Acting Injectable Buprenorphine in Veterans with Opioid Use Disorder
Implementation of an Integrated Dashboard and Automation Tool to Monitor Long-Acting Injectable Compliance for Veterans in an Outpatient Setting
Implementation of Naloxone Dispensing by Outpatient Clinical Pharmacists at a Rural Medical Facility
Implementing a Pharmacist-Led, Real-Time Clozapine Titration Workflow Using Rapid Therapeutic Drug Monitoring in an Inpatient Psychiatric Hospital
Improving Interpretation and Follow-up of Unexpected Urine Drug Screen Results in Veterans: A Prospective Chart Review
Improving Teratogenic Extreme Risk Drug Counseling in Veterans of Childbearing Potential
Increasing Access to Naloxone in Patients with Stimulant Use Disorder through AudioCARE System at the South Texas Veterans Health Care System
Increasing Access to Pharmacist Services within a Community Detoxification and Crisis Stabilization Facility
Inpatient Initiation of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil for the Treatment of Acute Exacerbations of Schizophrenia
Insomnia Among Pharmacy Students Using the Insomnia Symptom Questionnaire : A Cross-Sectional Survey Analysis
Integrating clinical pharmacy services into a psychiatric emergency room to improve patient outcomes at a Veterans Affairs Healthcare System
Learning about Long-Acting Injectable Antipsychotics (LAI-APs) Through Skills-Based Training
Longitudinal Integration of a Psychiatric Pharmacist into Outpatient Neurology Services for Veterans
Management of Lithium Therapy in Patients Undergoing Electroconvulsive Therapy at an Academic Medical Center
Managing Withdrawal from Very High Doses of Non-Prescribed Fentanyl During Low Dose Initiation of Buprenorphine: Pulling all the Stops
Medication Errors Identified Through Pharmacy-Led Medication Reconciliation in an Inpatient Behavioral Health Facility
Medication for Alcohol Use Disorder in Veterans with Co-occurring Alcohol and Opioid Use Disorders Receiving Buprenorphine: A Retrospective Review
Mind Matters: A Student-Led Mental Health Awareness Fair to Reduce Stigma and Promote Psychiatric Pharmacy
MiniBites: An Education Platform for Pharmacy Preceptors and Its Impact on Opioid Use Disorder Knowledge and Perceptions – A Pilot Study
Modification of Long-Acting Injectable Antipsychotic Guidelines within an Academic Health System
Multi-Site Pilot Evaluation of a Novel, Educational, Interprofessional Board Game, “Journey to Recovery,” as a Teaching and Learning Tool
Naltrexone Long-Acting Injectable for Concurrent 'Kratom Use Disorder' and Alcohol Use Disorder
Needs Assessment for Implementing Pharmacist-Driven Tardive Dyskinesia Monitoring in Pediatric Psychiatric Care
No REMS, No Roadmap? Navigating Clozapine Dispensing in Texas Community Pharmacies
Olanzapine and Samidorphan in Adults With Schizophrenia or Bipolar I Disorder: Updated Review of Clinical Data
Olanzapine Prescribing Practices Pre and Post Olanzapine Alert Implementation on Inpatient Psychiatric Units
Optimizing Phenobarbital Dosing in Obese Patients with Alcohol Withdrawal Syndrome: A Retrospective Evaluation of Actual Versus Ideal Body Weight-Based Strategies
Oral Supplementation of Long-Acting Injectable Second-Generation Antipsychotics in Adults with Serious Mental Illness
Outcomes of Pharmacist-Initiated Monitoring for Clozapine-Associated Myocarditis in Clozapine Naïve Psychiatrically Hospitalized Patients
Paranoia Associated with Venlafaxine Discontinuation: A Case Report
Patient-Reported Quality of Life and Functional Impact in Patients With Symptomatic Remission of Tardive Dyskinesia: Post Hoc Analyses From the Phase 4 KINECT-PRO™ Study
Pharmacist Burnout in North Carolina: A Cross Sectional Study on Prevalence and Contributing Factors
Pharmacists for Mental Health Equity: A Community Outreach Initiative
Pharmacological Management of Substance Use Disorders in the Older Adult Patient: A Narrative Review
Pharmacy Student Perceptions of Interprofessional Clinical Education During a Psychiatric Pharmacy Experience
Pharmacy Student Use of Artificial Intelligence (AI) During a Bipolar Disorder Therapeutics Case: Can you “out-smart” AI?
Piloting MOUD Maintenance Clinical Services in Community Pharmacies: A Hybrid Implementation–Effectiveness Study
Post-Launch Adverse Events Reported to FDA Adverse Event Reporting System for Long-Acting Injectable Buprenorphine
Prescribing Improvements Following Interventions to Reduce Anticholinergic Burden in Older Adults
Primidone-Induced Lumateperone Treatment Failure in a Patient with a History of Bipolar Depression
Promoting Evidence-Based Practices for Opioid Use Disorder: An Evaluation of the TEACH OUD Academic Detailing Initiative
Provider Perspectives on Barriers to Long-Acting Injectables
Psychiatric Pharmacist–Led Metabolic Monitoring Review for Patients Receiving Antipsychotics
Psychocardiology of Depression: Evidence-Based Interventions and Clinical Implications in Cardiovascular Disease
Psychonephrology Perspective on Psychotropic Medication–Related Nephrotoxicity in Renal Impairment: A Scoping Review
Psychotropic Medications in Psycho-Oncology for the Management of Chemotherapy-Related Cognitive Dysfunction: A Literature Review
Psychotropic Prescribing Patterns in Anorexia Nervosa Patients Presenting to an Inpatient Eating Disorders Program
Putting the ‘Person’ in Prescription: The Transformative Power of Lived Experience in Pharmacy Education
Rate of Hyponatremic Events Secondary to Antidepressant Use Within a Veteran Population
Re-evaluation of Medication Management to Prevent Restraint Episodes in Adult Patients Admitted to an Inpatient Psychiatric Facility Following Quality Improvement Efforts
Real-World Comparison of Olanzapine/Samidorphan vs Olanzapine: An Assessment of Treatment Patterns and Acute Care Events Among Patients With Schizophrenia or Bipolar I Disorder
Real-World Healthcare Utilization and Costs Associated With Using Dextromethorphan-Bupropion Extended-Release Tablets Versus Branded Comparators for the Treatment of Major Depressive Disorder
Real-World Impact of Olanzapine and Samidorphan on Rates of Relapse Among Young Adults With Schizophrenia or Bipolar I Disorder
Real-World Treatment Patterns and Clinical Management of Alzheimer’s Disease Agitation
Reasons Patients Deprescribe Benzodiazepines in the Veteran Affairs Health System
Recognition and Management of Methamphetamine-Induced Psychosis: A Focus Group Study
Reducing Sedative Use Through Pharmacist-Led Benzodiazepine Tapering (REST-RX) In Primary Care
Regulatory Challenges in Psychiatric Drug Development: Analyzing Approved Complete Response Letters
Remission With Lumateperone 42 mg Adjunctive to Antidepressant Therapy in Patients With Major Depressive Disorder: Analysis of Short-Term and Long-Term Trials
Resting State Electroencephalogram (EEG)-Based, Artificial Intelligence/Machine Learning (AI/ML) Biomarker for Predicting Treatment Response in Major Depressive Disorder (MDD)
Retrospective Review of Buprenorphine Prescribing Practices for Persistent Pain Management at a Veterans Affairs Medical Center
Retrospective Review of Dual Long-Acting Injectable Antipsychotic Use for Treatment-Resistant Schizophrenia
Rural Evaluation of Psychiatric Pharmacy to Improve Access to Mental Health Care and Healthcare Utilization (REACH Study)
Safety and Efficacy of Aripiprazole Lauroxil in an Outpatient Setting After Initiation During Hospitalization for an Acute Exacerbation of Schizophrenia
Spironolactone for Hormonal and Psychiatric Stabilization in Jacobs Syndrome: A Case Report
Sublingual Cyclobenzaprine for Nonrestorative Sleep in Fibromyalgia: A Scoping Review of the First FDA Approval in 15 years
Swallowing the Pain: Buprenorphine/Naloxone for Refractory Non-Suicidal Self-Injury in Borderline Personality Disorder
The Clozapine Initiative – Building a Sustainable Pharmacist-Led Pathway to Optimize Clozapine Utilization
The Effect of Long-Acting Injectable Buprenorphine on Healthcare Service Utilization
The Effectiveness of Automated Alerts in Enhancing Lithium Monitoring Adherence
The Evaluation of Clozapine Access Pre- and Post-REMS Removal
The Impact of Seizure First Aid Training on University Students, Faculty, and Staff
The Switch for Sleep: Doxepin vs. Trazodone and Treatment Outcomes for Insomnia on an Inpatient Psychiatric Unit
Theory of Planned Behavior Assessment of Experiences and Medication Attitudes in Pharmacist-Led Education Groups
Translating Interventions Into Outcomes: What Drives Clinical Improvement Among Patients Referred to a Psychiatric CMM Pharmacist?
Treatment-Resistant Depression: Assessing Feasibility of Centralized TRD Consultation for Somatic Therapy Referrals
Understanding Substance Use Disorder Prescribing Practices In a State-Operated Psychiatric Hospital
Use of Injectable Medications for Pediatric Agitation: Comparison Across Different Levels of Care
Use of Intramuscular Ziprasidone and Intramuscular Diphenhydramine in combination with Intramuscular Lorazepam or Intramuscular Midazolam in the Management of Acute Agitation in a Psychiatric Care Facility​
Using a Needs Assessment Approach to Guide Future Development of Educational Material for Psychiatric Providers and Pharmacists on Clozapine Use and Monitoring
Utilization of Extended-Release Buprenorphine at a Tertiary Medical Center
Utilization of Methadone in the Post-COVID-19 Era
Utilization of Naloxone Nasal Spray at Discharge in Psychiatric Inpatients with Opioid Use Disorder
Utilizing SQL-Based Data Extraction to Support Clinical Evaluation and Dashboard Development for Antipsychotic-Induced Metabolic Effects
Valbenazine Improves Patient-Reported Quality of Life, Functional Impact, and Abnormal Movements of Tardive Dyskinesia: Results From the Phase 4 KINECT‑PRO™ Study
Viral Infection as a Possible Modifier of Neuroleptic Malignant Syndrome: a Systematic Review
When Antibiotics Affect the Brain: Epidemiology, Mechanisms, and Clinical Management of Antibiotic-Induced Neuropsychiatric Toxicity
Zuranolone’s Role in Restoring GABAergic Inhibition in Postpartum Depression: A Literature Review